Schedule I and Schedule II drugs; adds various drugs to lists. (HB1440)

Introduced By

Del. Scott Garrett (R-Lynchburg)

Progress

Introduced
Passed Committee
Passed House
Passed Senate
Signed by Governor
Became Law

Description

Schedule I and Schedule II drugs. Adds MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) to Schedule I of the Drug Control Act and Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration to Schedule II of the Drug Control Act and removes naldemedine from Schedule II of the Drug Control Act. Amends § 54.1-3446, § 54.1-3448, of the Code of Virginia. Read the Bill »

Status

02/28/2018: Passed the Senate

History

DateAction
01/16/2018Committee
01/16/2018Presented and ordered printed 18104387D
01/16/2018Referred to Committee on Health, Welfare and Institutions
01/17/2018Impact statement from VCSC (HB1440)
01/23/2018Impact statement from VDH (HB1440)
01/25/2018Reported from Health, Welfare and Institutions (22-Y 0-N) (see vote tally)
01/25/2018Referred to Committee on Appropriations
01/29/2018Assigned App. sub: Public Safety
02/08/2018Subcommittee recommends reporting (8-Y 0-N)
02/09/2018Reported from Appropriations (22-Y 0-N) (see vote tally)
02/10/2018Read first time
02/12/2018Read second time and engrossed
02/13/2018Read third time and passed House BLOCK VOTE (100-Y 0-N)
02/13/2018VOTE: BLOCK VOTE PASSAGE (100-Y 0-N) (see vote tally)
02/14/2018Constitutional reading dispensed
02/14/2018Referred to Committee on Education and Health
02/22/2018Reported from Education and Health (15-Y 0-N) (see vote tally)
02/22/2018Rereferred to Finance
02/27/2018Reported from Finance with amendment (16-Y 0-N) (see vote tally)
02/28/2018Constitutional reading dispensed (40-Y 0-N) (see vote tally)
02/28/2018Read third time
02/28/2018Reading of amendment waived
02/28/2018Committee amendment agreed to
02/28/2018Engrossed by Senate as amended
02/28/2018Passed Senate with amendment (40-Y 0-N) (see vote tally)
02/28/2018Senate amendment rejected by House (0-Y 94-N)
02/28/2018VOTE: REJECTED (0-Y 94-N) (see vote tally)
02/28/2018Senate insisted on amendment (40-Y 0-N) (see vote tally)
02/28/2018Senate requested conference committee
02/28/2018Placed on Calendar
02/28/2018House acceded to request
02/28/2018Conferees appointed by Senate
02/28/2018Senators: Peake, Dunnavant, Locke
02/28/2018Conferees appointed by House
02/28/2018Delegates: Garrett, Orrock, Aird
03/10/2018Failed to pass in House
03/10/2018No further action taken
03/10/2018Failed to pass